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Abstract
Native 5-HT3 and AChR ligand-gated cation channels can be inhibited (blocked) by the non-steroidal antioestrogen
tamoxifen. However, the exact site and mechanism of inhibition by tamoxifen on these channels remain unclear. We have
investigated the action of the membrane impermeant quaternary derivative, ethylbromide tamoxifen (EBT), on native ligand-
gated 5-HT3 receptor channels and voltage-gated K channels in NG108-15 cells using whole cell patch clamp. Extracellular
EBT inhibited whole cell cationic currents of 5-HT3 receptors with IC50 of 0.22 þ 0.4 WM (nH = 1.05 þ 0.2). The channel block
was characterised by voltage independent and use independent behaviour (similar to that of tamoxifen). EBT was unable to
inhibit voltage-gated K currents in NG108-15 cells. This was in contrast to the inhibition by tamoxifen which, at similar
concentrations, accelerated the apparent inactivation of these outward K currents. The inhibition of 5-HT3 receptors by a
membrane impermeant derivative of tamoxifen supports the view that the binding site for antioestrogens is extracellular and
the inhibition is not mediated through genomic/transcriptional activity. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In addition to antioestrogenic activity, tamoxifen
has been shown to interfere with a number of cellular
targets including calmodulin and protein kinase C
activity [1,2]. Several groups have shown that tamox-
ifen is able to inhibit various plasma membrane ion
channels [3^7]. We previously described the action of
tamoxifen on the ligand-gated 5-HT3 and AChR
channels [7]. The inhibition of the 5-HT3 receptor
currents was consistent with a non-competitive mech-
anism of block but the site could not be determined.
It was postulated that non-steroidal antioestrogens
interact directly with allosteric sites on ion channels
[7].
To identify the site of action of non-steroidal anti-
oestrogens we have investigated the channel blocking
properties of tamoxifen and the membrane imperme-
ant derivative ethylbromide tamoxifen (EBT). Both
EBT and tamoxifen are oestrogen-receptor antago-
nists but the quaternary derivative (EBT) is unable
to cross cell membranes and bind to intracellular
targets, consequently tamoxifen but not EBT can
inhibit oestrogen dependent proliferation in MCF-7
cells [8]. Membrane impermeant quaternary com-
pounds are used to determine the site and mechanism
of channel block [9]. In this study we investigate the
action of tamoxifen and a quaternary derivative on
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voltage-gated and ligand-gated ion channel activity
in the same cell type.
2. Materials and methods
2.1. Culture of neuroblastomaUglioma hybrid cells
Mouse neuroblastomaUrat glioma hybrid cells,
NG108-15, were grown in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM+Glutamax) supplemented
with 10% foetal calf serum, 2% hypoxanthine, ami-
nopterin and thymidine (HAT) supplement and 50
Wg/ml gentamicin. The undi¡erentiated cells were
plated at a density of approx. 5U104 cells per 35
mm diameter culture dish at least 24 h before use.
2.2. Whole cell patch clamp recording
Agonist activated macroscopic currents were re-
corded from single cells by whole-cell patch clamp
techniques as described previously [7]. NG108-15
cells were continuously superfused with an extracel-
lular solution containing (in mM): 136 NaCl, 2.6
CaCl2, 2.4 KCl, 1.2 MgCl2, 15 HEPES, 10 glucose,
pH 7.4 at 23 þ 2‡C. Patch electrodes were ¢lled with
a solution containing (in mM): 110 KCl, 3.0 MgCl2,
40 HEPES, 3 EGTA (titrated with KOH to pH 7.4)
[10].
2.3. Agonist application
Agonist induced currents were recorded from
NG108-15 cells voltage clamped at a membrane po-
tential of 380 mV. The cell being recorded from was
continuously superfused with extracellular bathing
solution as described previously.
Application of agonist was for 5 s and the appli-
cations were repeated every 90 s to avoid desensitisa-
tion using a fast-step motored perfusion system (SF-
77 Warner Instruments) [7]. Raw output signals from
the patch clamp ampli¢er were ¢ltered with a low
bandpass ¢lter at 5 kHz, and digitised at 1 kHz.
Macroscopic currents recorded in response to the
application of 5-HT were analysed o¡ line. Records
were not leak subtracted. The decaying phases of
current responses during desensitisation were ¢tted
to the sum of two exponential functions by minimi-
sation of the sum of squared deviations (WCP v1.6;
Strathclyde Electrophysiological Software).
2.4. Data analysis
Agonist responses from each cell were normalised
to the 10 WM 5-HT response. Concentration-inhibi-
tion curves were ¢tted iteratively using Fig P soft-
ware (Biosoft, Cambridge) to the following equation:
I  13Imax=1 IC50=AnH 1
where [A] is the concentration of antagonist, Imax is
the maximum normalised current response (in the
absence of antagonists), IC50 is the concentration
of antagonist to produce 50% inhibition and nH is
the Hill coe⁄cient.
2.5. Voltage-gated potassium channels
Voltage-gated potassium channels were recorded
from undi¡erentiated NG108-15 cells clamped at a
holding potential of 380 mV and outward K cur-
rents were evoked by stepwise changes in membrane
potential lasting for 0.5 or 5 s. Raw output currents
were ¢ltered with a low bandpass ¢lter at 5 kHz, and
digitised at 2 kHz using a CED 1401 interface con-
nected to a PC 486 computer running WCP v1.6
patch clamp software.
2.6. Drugs
Tamoxifen base was obtained from Sigma-Aldrich
and EBT was synthesised as described below based
on a method of Jarman [8].
2.6.1. Quaternisation of tamoxifen
Tamoxifen (1 g) was added to ethylbromide (35
ml) and stirred overnight at room temperature. The
reaction mixture was ¢ltered and the white solid col-
lected was crystallised from ethanol in toluene as
colourless needles to give the quaternary salt m.p.
166^168‡C ([8], 158^159‡C); (found C, 67.59; H,
7.27; N, 2.80 C28H34ONBr. H2O calc. for C, 67.72;
H, 7.10; N, 2.75); NH (360 MHz; CDCl3): 0.94 (3H,
t, J 7.4 Hz, CH3CH2C), 1.41 (3H, t, J 7.4 Hz,
CH3CH2N), 2.47 (2H, q, J 7.4 Hz, CH3CH2C),
3.42 [6H, s, N(CH3)2] 3.77 (2H, q, CH3CH2N),
6.55 (2H, Abq, J 8.5 Hz, C6H4OCH2, ortho H),
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6.83 (2H, Abq, J 8.5 Hz, C6H4OCH2, meta H) 7.11^
7.39 (10H, m, 2Ph). The 1H NMR spectrum was
determined in deuterochloroform with tetramethylsi-
lane as an internal standard, at 360 MHz with a
Bruker WM 360 spectrometer. The melting point
was determined on an electrothermal melting point
apparatus and is uncorrected for temperature and
pressure. The purity of EBT was greater than 98%
as determined by elemental analysis. All of the chem-
icals used were obtained from Aldrich.
Tamoxifen and EBT stock solutions were dis-
solved in dimethyl sulphoxide at a concentration of
10 mM, and subsequently diluted in extracellular so-
lution to give ¢nal concentrations of 0.01^10 WM.
The concentration of dimethyl sulphoxide in the per-
fusion medium did not exceed 0.1%: these concen-
trations had no signi¢cant e¡ect on 5-HT gated cur-
rents in NG108-15 cells expressing native 5-HT3
receptors and delayed recti¢er type potassium cur-
rents.
2.7. Statistics
Values reported are mean þ S.E.M. Mean values
were compared using paired and unpaired two tailed
t-tests as appropriate. P6 0.05 was considered sig-
Fig. 1. Inhibition of 5-HT responses by non-steroidal antioestrogens. (A) Inhibition of responses to brief application of 5-HT (10 WM,
black bars, F) during and after exposure to EBT (1 WM) for 4.5 min (hatched bar). (B) Inhibition of 5-HT (10 WM, F) responses after
exposure to EBT (1 WM, 4.5 min, hatched bar) with sham exposure of 5-HT (E). (C) Summary of data obtained in A (b) and B (E)
during exposure to EBT (n = 4 cells for both conditions). (D) Concentration-inhibition curve. The IC50 was 0.81 þ 0.2 WM,
nH = 1.3 þ 0.3 for tamoxifen (b) and 0.22 þ 0.4 WM, nH = 1.05 þ 0.2 for EBT (E). Each point represents the data obtained from four in-
dividual cells. Each cell was exposed to only one concentration of tamoxifen. The open circle (a) represents the currents obtained by
the vehicle control (DMSO) at the highest concentration used. DMSO did not signi¢cantly reduce the 5-HT responses (Ps 0.05).
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ni¢cant. Current-voltage (IV) relationships were
compared using two-way analysis of variance with
replication.
3. Results
3.1. Inhibition of 5-HT3 receptor currents by EBT
A typical trace of the currents evoked in NG108-
15 cells by a brief (5 s) exposure to 10 WM 5-HT is
shown in Fig. 1. Currents induced by 10 WM 5-HT
were blocked by 10 nM d-tubocurarine and tropise-
tron (10 nM) as reported previously [7]. Likewise, we
previously demonstrated that these currents are also
blocked by tamoxifen in a concentration dependent,
non-competitive manner [7]. Fig. 1A shows that 1 WM
EBT also completely inhibits the 5-HT induced cur-
rent by the third application of 5-HT (representing
250 s exposure to EBT). This inhibition was concen-
tration dependent, with an IC50 of 0.22 þ 0.38 WM
and had a Hill coe⁄cient of 1.1 þ 0.2 (Fig. 1D).
The inhibition at low concentrations (91 WM) could
be reversed but at higher concentrations reversibility
was incomplete during the course of the experiment.
3.2. Absence of use dependence of block of 5-HT3
receptors by EBT
A feature of inhibition of 5-HT currents by tamox-
ifen is the lack of use dependent blockade [7]. Expo-
sure to EBT (1 WM) progressively inhibited the re-
sponses to 5-HT (10 WM) with steady state inhibition
obtained after two applications of 5-HT (Fig. 1A,C).
Fig. 1B shows a control experiment with sham ap-
plication of 5-HT (extracellular solution alone) dur-
ing exposure to 1 WM EBT. After three sham appli-
cations of the agonist the EBT was removed and
recovery from blockade followed; it can be seen
that the inhibition of 5-HT evoked currents was sim-
ilar to that obtained in Fig. 1A. Fig. 1C shows the
inhibition of the currents by EBT, which appears
time dependent rather than use dependent as expo-
sure to EBT alone can inhibit subsequent 5-HT re-
sponses. Recovery from EBT (1 WM) during these
long experiments was incomplete during the 5 min
washout.
3.3. Lack of voltage dependence of block of 5-HT3
receptor currents by EBT
Previously we showed that tamoxifen blocks 5-HT
responses in a voltage independent manner [7]. Con-
sequently, the inhibitory e¡ect of 0.1 WM EBT on 5-
HT responses at a range of holding potentials was
examined. The inhibition observed did not appear to
be voltage dependent over the range of 380 to +40
mV as illustrated by the representative traces in Fig.
2A. The mean current-voltage relationship with and
without EBT is shown in Fig. 2B, and proportional
reductions of current at di¡erent holding potentials
are shown in Fig. 2C. The slope of the line was not
signi¢cantly di¡erent from zero (Ps 0.05).
3.4. The e¡ect of EBT on 5-HT3 receptor
desensitisation
Other non-competitive inhibitors of 5-HT3 recep-
tors in neuronal cell lines have been shown to in-
crease the rate of desensitisation [7,11,12]. The e¡ect
of EBT on the 5-HT evoked currents was investi-
gated accordingly. After an initial period of stabili-
sation upon achieving whole cell recording condi-
tions, stable 5-HT responses could be recorded and
the desensitisation of the inward current could be
described by a bi-exponential decay process (Fig.
2D). The time course of desensitisation was quanti-
¢ed by curve ¢tting of the decaying phases of re-
sponses to the sum of two exponentials. Under con-
trol conditions the kinetic parameters obtained from
the double exponential ¢ts gave a fast time constant
(d1) of 595 þ 150 ms and a slow time constant (d2) of
5.74 þ 1.7 s (n = 5). The mean values for the fast de-
sensitisation component were signi¢cantly reduced
following exposure to 100 nM EBT for 270 s
(d1 = 326 þ 65 ms, n = 5, P6 0.05 versus control);
the mean values for the slow desensitisation compo-
nent were una¡ected by exposure to 100 nM EBT for
270 s (d2 = 4.0 þ 1.3 s, n = 5; Ps 0.05). EBT, like ta-
moxifen, did not signi¢cantly a¡ect the rise time (10^
90%) of the response to 5-HT (control = 135 þ 34 ms;
EBT = 131 þ 50 ms; n = 5; Ps 0.05).
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3.5. The e¡ect of tamoxifen and EBT on voltage-
gated potassium channels in NG108-15 cells
Tamoxifen is known to inhibit delayed recti¢er
type potassium channels and this inhibition has
been demonstrated in several cell types [6,13]. We
have examined the e¡ects of both tamoxifen and
EBT on voltage-gated potassium channels in
NG108-15 cells (Fig. 3). Tamoxifen (0.1^10 WM)
slowly (s 2 min) inhibited voltage-gated potassium
currents in a concentration dependent manner (Fig.
3A,B, data summarised in Fig. 3C). EBT (0.1^3 WM),
however, was without e¡ect on these currents at con-
centrations of EBT up to 5 WM (Fig. 3D,E, data
summarised in Fig. 3F). The inactivation rates of
the potassium currents were signi¢cantly increased
by tamoxifen (control = 1872 þ 245 ms; tamoxi-
fen = 643 þ 120 ms; n = 6; P6 0.01), whereas there
was no signi¢cant e¡ect with EBT (con-
trol = 1895 þ 115 ms; EBT = 1734 þ 72 ms; n = 5;
Ps 0.05) (Fig. 4).
The lipophilicity of tamoxifen could result in chan-
nel block occurring via the cytosolic face of the chan-
nel, having di¡used through the plasma membrane.
However, intracellular application of EBT (via the
pipette solution) at 10 WM for up to 15 min had
no obvious e¡ect on the size of the currents nor
the inactivation rates (n = 5), indicating that antioes-
trogens do not have to gain access to the cytoplasm
in order to inhibit delayed recti¢er (DR) type potas-
sium currents.
Fig. 2. Lack of e¡ect of EBT on the voltage dependence of 5-HT induced currents. (A) Representative traces of currents evoked by
10 WM 5-HT at di¡erent holding potentials in one cell before, and during a 10 min application of 100 nM EBT. (B) 5-HT response-
amplitude plotted as a function of membrane potential before (F) and during (E) EBT (100 nM) application (n = 5). (C) The ratio of
the mean currents shown in B are plotted against holding potential and illustrate the lack of voltage dependent inhibition (F) by EBT
(100 nM). (D) Representative current responses evoked by 10 WM 5-HT in the presence (upper trace) and absence (lower trace) of
100 nM EBT. The decaying phase was ¢tted to the sum of two exponentials and the time constants for both conditions are shown.
Tamoxifen inhibited the peak response and increased the desensitisation rate.
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4. Discussion
Previously, we reported that tamoxifen was able to
inhibit 5-HT3 currents in NG108-15 cells by a non-
competitive mechanism [7]. We were unable to dis-
tinguish between a direct e¡ect on the channel or an
intracellular e¡ect on second messenger systems
(such as modulation of protein kinase C [14]). The
fact that we have shown that both tamoxifen and the
membrane impermeant EBT can inhibit neuronal 5-
HT3 currents at similar concentrations makes it un-
likely that non-steroidal antioestrogens inhibit 5-HT3
channels after crossing the membrane. Again, we
cannot exclude the possibility that the impermeant
derivative does not trigger a signalling event through
binding to a membrane receptor. The data presented
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here do exclude a direct blocking e¡ect on the cyto-
solic face of the membrane.
The inhibition curves for tamoxifen and EBT gave
similar Hill coe⁄cients of approx. 1 for the 5-HT3
receptors which indicates a single binding site on the
channel. As we have shown that tamoxifen exhibits
time dependent and not use dependent block, we
suspected that the inhibitory site on the channel
was accessed from within the lipid bilayer [7]. EBT,
however, is unlikely to fully partition into a lipid
bilayer because of its positively charged quaternary
group. Consequently, the binding site for non-steroi-
dal antioestrogens is most likely on the extracellular
domain of the channel rather than the intracellular
or hydrophobic membrane spanning region.
The e¡ect of tamoxifen on DR type potassium
currents is to reduce peak outward current and accel-
erate the inactivation rate whereas intracellular or
extracellular application of EBT was without detect-
able e¡ect. Small hydrophilic quaternary ammonium
compounds have been shown to accelerate the inac-
tivation rate of DR currents with minimal e¡ect on
rise times and peak currents [9]. The results obtained
with EBT do not follow this pattern but instead in-
dicate that the site of action of these antioestrogens
on the DR type potassium channel is within the lipid
membrane.
In conclusion, membrane impermeant non-steroi-
dal antioestrogens inhibit 5-HT3 receptors but not
delayed recti¢er type potassium currents in NG108-
15 cells. The inhibition of 5-HT3 receptors appears to
be non-competitive, voltage independent and use in-
dependent. Hill coe⁄cient values indicate that bind-
ing is probably to a single extracellular site to which
antioestrogens have access while the channel is in the
closed conformation. The use of a quaternary tamox-
ifen in this series of experiments eliminates an intra-
cellular binding location for both 5-HT3 and DR
type potassium channels. The rapid inhibition of
the 5-HT3 receptor currents by EBT is not mediated
via nuclear oestrogen receptor binding or direct mod-
ulation of intracellular enzymes.
Fig. 4. The e¡ects of antioestrogens on voltage-gated DR type
potassium current inactivation. Cells were held at a membrane
potential of 380 mV and the potential changed to +60 mV for
5 s to activate the potassium currents. (A) The e¡ects of 3 WM
tamoxifen on potassium current inactivation. (B) The e¡ect of
3 WM EBT on potassium current inactivation. A and B were
measured after 3 min exposure to antioestrogens.
Fig. 3. The e¡ects of antioestrogens on voltage-gated delayed recti¢er type potassium currents. The cells were clamped at a Vhold 380
mV and 300 ms depolarising steps from 370 to 70 mV were applied every 5 s to evoke delayed recti¢er type potassium currents. Con-
trol potassium currents are illustrated in A, whilst the e¡ect of 3 min application of 3 WM tamoxifen to the same cell is illustrated in
B. These experiments were repeated in four di¡erent cells for each concentration of tamoxifen investigated and the results summarised
in C. C shows a normalised peak current-voltage (IV) relationship under control conditions and in the presence of di¡ering concentra-
tions of tamoxifen (n = 4): E, in HEPES Ringer; a, vehicle control; R, tamoxifen 0.3 WM; 8, tamoxifen 1 WM; b, tamoxifen 3 WM;
D, tamoxifen 10 WM. The DMSO vehicle control and tamoxifen 0.3 WM did not signi¢cantly inhibit the voltage activated currents,
but there was a signi¢cant inhibition with tamoxifen 1 WM, 3 WM and 10 WM tamoxifen (P6 0.01). The insert illustrates the inhibition
of DR currents by increasing concentrations of tamoxifen. Mean values were taken from currents evoked at +50 mV. Control potassi-
um currents are illustrated in D, whilst the e¡ect of 3 min application of 3 WM EBT to the same cell is illustrated in E. These experi-
ments were repeated in seven di¡erent cells for each concentration of EBT investigated and the results summarised in F. F shows a
normalised peak current-voltage (IV) relationship under control conditions or in the presence of di¡ering concentrations of EBT
(n = 7): E, in HEPES Ringer; a, vehicle control; R, EBT 0.3 WM; 8, EBT 1 WM; b, EBT 3 WM. The DMSO vehicle control and
all concentrations of EBT did not signi¢cantly inhibit the voltage activated currents (Ps 0.05).
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